![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Categories list
AlcoholismAlzheimer's And Parkinson'sAnalgesicsAnti-inflammatoriesAntiallergicAntibioticsAnticonvulsantsAntidepressantsAntifungalsAntiparasiticAntiviralsArthritisAsthmaBirth ControlCancerCardiovascular DiseasesCholesterolDiabetesDiureticsErectile DysfunctionEye CareGastrointestinal TractH I VHypertensionMen's HealthMental DisordersMigraineMuscle RelaxantsNeurological DisordersObesityOsteoporosisRespiratory TractSkin CareSurgeryUrinary TractWomen's Health 18 May 2012 04:08:20
Plaintiffs Have No Standing to Sue Over Off-Label Drug Uses Law.com Plaintiffs Have No Standing to Sue Over Off-Label Drug Uses Law.com Angela Montgomery failed to show that her doctor prescribed the medicine, Rebetol , because of Schering-Plough's marketing strategy, the Third Circuit held in its 35-page opinion in In re Schering-Plough . The New Jersey-based drug company pleaded ...16 May 2012 11:15:59
Hyman, Phelps, & McNamara, PC | Decisions, Decisions, Decisions! Our Updated ...Hyman, Phelps, & McNamara, PC Decisions, Decisions, Decisions! Our Updated ... Linex Legal (press release) (registration) FDA-2003-P-0074 (Apr. 6, 2004) â REBETOL (ribavirin) FDA Response, Docket No. FDA-2005-P-0368 (Dec. 1, 2006) â OXANDRIN (oxandrolone) FDA Response, Docket No. FDA-2006-P-0274 (Mar. 13, 2008) â ETHYOL (amifostine) FDA Response, Docket No.
16 May 2012 06:08:18
Experts Discuss DAAs for Difficult-To-Treat Hep C Patients Infectious Disease Special Edition Experts Discuss DAAs for Difficult-To-Treat Hep C Patients Infectious Disease Special Edition ... during the four-week Peg-IFN and ribavirin lead-in during the RESPOND-2 (Retreatment with HCV Serine Protease Inhibitor Boceprevir and PegIntron Rebetol 2) and SPRINT-2 (Serine Protease Inhibitor Therapy 2) Phase III trials (Bacon BR et al.27 Apr 2012 14:20:05
2 Biotech Stocks That Could Jump On Hepatitis C Breakthroughs2 Biotech Stocks That Could Jump On Hepatitis C Breakthroughs Seeking Alpha Ribavirin drugs include Rebetol and Copegus, made by Schering-Plough and Roche Pharmaceuticals, respectively. When combined with interferons, ribavirins work much like antibiotics. There are also several investigational drugs being studied in the ...
|
|
Choose Your language:
Site search:
Testimonials
You have been fabulous to work with and I will clearly recommend your service and use it again myself.
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Bestsellers|Policies|Frequently Asked Questions|Testimonials|Contact us|Sitemap |
|
|
|
|
| |